-
Mashup Score: 0The Texas Heart Institute Collaborates with Aviara Pharmaceuticals, Inc. to Develop Novel IBD Drug - 7 month(s) ago
HOUSTON (Sept. 26, 2023) — Aviara Pharmaceuticals, Inc., through a research collaboration with The Texas Heart Institute® (THI), recently was awarded a two-year, $1.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to develop a safe and novel drug for inflammatory bowel disease (IBD). IBD is characterized by chronic inflammation of the digestive […]
Source: www.texasheart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1The Heart Beat: Dr. Joseph G. Rogers, THI President and CEO | A Vision for the Future - 2 year(s) ago
The Heart Beat Episode 9: THI’s new President and CEO Dr. Joseph G. Rogers sits down with host Maya Pomroy to unveil the renewed mission at the Texas Heart …
Source: YouTubeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Texas Heart Medical Group - 3 year(s) ago
The multi-cultural Texas Heart Medical Group practice is affiliated with the world-renowned Texas Heart Institute, specializing in comprehensive cardiovascular care.
Source: Texas Heart Medical GroupCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Texas Heart Medical Group - 3 year(s) ago
The multi-cultural Texas Heart Medical Group practice is affiliated with the world-renowned Texas Heart Institute, specializing in comprehensive cardiovascular care.
Source: Texas Heart Medical GroupCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Machine Learning And Artificial Intelligence In Medicine - 3 year(s) ago
Dr. Zain Khalpey presenting at the Texas Heart Institute 2021 Perfusion Conference.
Source: YouTubeCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Myocarditis in the Era of COVID | Texas Heart Institute - 3 year(s) ago
Myocarditis simply means inflammation of the heart muscle. This is a relatively rare condition that most doctors encounter only occasionally. The severity of this inflammation can range from mild, causing minimal symptoms like a bit of chest discomfort and shortness of breath, to severe, causing the heart to fail, which can result in death in the worst cases.
Source: www.texasheart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
Aviara Pharmaceuticals, through a research collaboration with THI, recently received a $1.9 million NIH grant to develop a novel drug for IBD. https://t.co/OhxxTgtwqa #texasheartinstitute #texasheart #IBD https://t.co/3Ni9ySyqyT